Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Life sciences company Rhone-Poulenc S.A. (NYSE: RP) fell $2 1/8 to $37 13/16 and pharmaceutical and chemical company Hoechst AG (NYSE: HOE) lost $1 1/2 to $37 7/8 after announcing that their Centeon joint venture will only restart production at its facility in Kankakee, Illinois, on products deemed "medically necessary" by the Food and Drug Administration. Production had been suspended following a recent FDA inspection. Centeon estimates that the cutback in production could lead to a net loss of $80 million to $150 million, which would be shared equally by the two parent companies. Besides the Centeon joint venture, Rhone-Poulenc said its businesses are "evolving in line with expectations" so far this year, but the company remains "cautious" for the rest of the year because of uncertainty in the global economic climate. Meanwhile, Hoechst warned that it expects a drop in 1998 earnings due to weakness in Asia, Latin America, and Russia.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.